ArticleFrontiers in immunology2022

A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.

Haoyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.